SPC revocation decision on alzheimer treatment medication Memantine has delayed in UK. The Judge in the UK came to the conclusion that he needed to refer questions on the legal interpretation of the SPC Regulation to the European Court of Justice for clarification of the position. The said decision can further take some time, however, commercially, generic player Synthon (who has opposed the SPC) will have to wait for final decision from court.
Link to court decision Here
Friday, 24 April 2009
Memantine: SPC revocation decision delayed
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment